Ignite Creation Date:
2025-12-24 @ 3:25 PM
Ignite Modification Date:
2026-02-24 @ 10:51 AM
Study NCT ID:
NCT00684892
Status:
COMPLETED
Last Update Posted:
2009-01-22
First Post:
2008-05-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Feasibility Study of the Chartis System With Heterogeneous Emphysema Prior to Endobronchial Lung Volume Reduction (ELVR)
Sponsor:
Pulmonx Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PRT01029
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Carol Anne Yarbrough, RN, Director, Clinical Affairs
Old Organization:
Pulmonx, Inc.